Go High in the field of clinical pharmacy

LIST OF PUBLICATION:

1. Arun Kumar Sharma, Shaikh Haidarali, Upendra Nagaich. Apoptosis: A Potential target site for natural bioactive agents during myocardial infarction; J. Adv. Pharm. Edu. & Res. 2014: 4(3): 264-284., Impact Factor: 3.485.

2. Sameer N. Goyal, Arun Kumar Sharma, Shaikh Haiderali, Navya Reddy M, Dharamvir Singh Arya and Chandragouda R. Patil. Prediabetes: ground of pitfall signaling alteration for cardiovascular disease. RSC Adv 2014; 4, 58272-58279., Impact Factor: 3.708.


3. Sharma Arun Kumar, Khanna Deepa and Balakumar Pitchai. Low-dose dipyridamole treatment partially prevents diabetes mellitus-induced vascular endothelial and renal abnormalities in rats. International journal of Cardiology, doi: 10.1016/j.ijcard.2014.01.053., Impact Factor: 6.175.

4. Sharma AK and Khanna D. Diabetes melitus associated cardiovascular signalling alteration: A need for the revisit. Cell Signal. 2013; 25:1149-55. Impact Factor: 4.471.

5. Jaiman S, Sharma AK, Singh K, Khanna D. Signalling mechanisms involved in renal pathological changes during cisplatin-induced nephropathy. Eur J Clin Pharmacol. 2013; 69: 1863-74., Impact Factor: 2.617.

6. Pitchai Balakumar, Harish Kumar Bishnoi, Supriya Kadian, Arun Kumar Sharma, Nanjaian Mahadevan. Therapeutic Efficacy of Combined Fenofibrate and Statin Therapy. International Journal of Recent Advances in Pharmaceutical Research 2012; 2: 41-44.

LIST OF ARTICLE IN COMMUNICATION:

1. Arun Kumar Sharma­*, Prashant Ramdas Gore, Albiglutide: Indeed a better hope versus diabetes mellitus? (Communicated with Diabetes Research and Clinical Practice, Ms. Ref. No.: DIAB-D-14-00703).

2. Arun Kumar Sharma*, Reactive oxygen species: friend or foe? (Communicated with Free Radical Research,